GH RESEARCH PLC (GHRS) Fundamental Analysis & Valuation

NASDAQ:GHRS • IE000GID8VI0

Current stock price

20.25 USD
+1.44 (+7.66%)
At close:
21.7114 USD
+1.46 (+7.22%)
After Hours:

This GHRS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. GHRS Profitability Analysis

1.1 Basic Checks

  • GHRS had negative earnings in the past year.
  • GHRS had a negative operating cash flow in the past year.
  • In the past 5 years GHRS always reported negative net income.
  • GHRS had a negative operating cash flow in each of the past 5 years.
GHRS Yearly Net Income VS EBIT VS OCF VS FCFGHRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • The Return On Assets of GHRS (-16.74%) is better than 62.30% of its industry peers.
  • GHRS has a Return On Equity of -17.25%. This is in the better half of the industry: GHRS outperforms 70.68% of its industry peers.
Industry RankSector Rank
ROA -16.74%
ROE -17.25%
ROIC N/A
ROA(3y)-17.72%
ROA(5y)-13.06%
ROE(3y)-18.43%
ROE(5y)-13.52%
ROIC(3y)N/A
ROIC(5y)N/A
GHRS Yearly ROA, ROE, ROICGHRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for GHRS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GHRS Yearly Profit, Operating, Gross MarginsGHRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. GHRS Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for GHRS has been increased compared to 1 year ago.
  • Compared to 5 years ago, GHRS has more shares outstanding
  • The debt/assets ratio for GHRS has been reduced compared to a year ago.
GHRS Yearly Shares OutstandingGHRS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
GHRS Yearly Total Debt VS Total AssetsGHRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 81.88 indicates that GHRS is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 81.88, GHRS belongs to the best of the industry, outperforming 96.34% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that GHRS is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.00, GHRS is doing good in the industry, outperforming 61.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 81.88
ROIC/WACCN/A
WACCN/A
GHRS Yearly LT Debt VS Equity VS FCFGHRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • GHRS has a Current Ratio of 34.13. This indicates that GHRS is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 34.13, GHRS belongs to the best of the industry, outperforming 97.91% of the companies in the same industry.
  • GHRS has a Quick Ratio of 34.13. This indicates that GHRS is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of GHRS (34.13) is better than 97.91% of its industry peers.
Industry RankSector Rank
Current Ratio 34.13
Quick Ratio 34.13
GHRS Yearly Current Assets VS Current LiabilitesGHRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. GHRS Growth Analysis

3.1 Past

  • GHRS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.67%.
EPS 1Y (TTM)-6.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-35.29%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, GHRS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.19% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-85.9%
EPS Next 2Y-52.17%
EPS Next 3Y-36.43%
EPS Next 5Y18.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GHRS Yearly Revenue VS EstimatesGHRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
GHRS Yearly EPS VS EstimatesGHRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

0

4. GHRS Valuation Analysis

4.1 Price/Earnings Ratio

  • GHRS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year GHRS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GHRS Price Earnings VS Forward Price EarningsGHRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GHRS Per share dataGHRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

  • A cheap valuation may be justified as GHRS's earnings are expected to decrease with -36.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-52.17%
EPS Next 3Y-36.43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GHRS Dividend Analysis

5.1 Amount

  • No dividends for GHRS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GHRS Fundamentals: All Metrics, Ratios and Statistics

GH RESEARCH PLC

NASDAQ:GHRS (4/24/2026, 8:00:01 PM)

After market: 21.7114 +1.46 (+7.22%)

20.25

+1.44 (+7.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-05
Earnings (Next)05-07
Inst Owners74.93%
Inst Owner Change0%
Ins Owners26.78%
Ins Owner Change0%
Market Cap1.26B
Revenue(TTM)N/A
Net Income(TTM)-48.26M
Analysts84
Price Target40.03 (97.68%)
Short Float %4.88%
Short Ratio11.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.6%
Min EPS beat(2)4.72%
Max EPS beat(2)16.49%
EPS beat(4)4
Avg EPS beat(4)26.16%
Min EPS beat(4)4.72%
Max EPS beat(4)52.24%
EPS beat(8)8
Avg EPS beat(8)24.33%
EPS beat(12)11
Avg EPS beat(12)23.82%
EPS beat(16)14
Avg EPS beat(16)27.04%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)18.94%
PT rev (3m)20.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)28.12%
EPS NY rev (1m)11.71%
EPS NY rev (3m)11.71%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.49
P/tB 4.49
EV/EBITDA N/A
EPS(TTM)-0.8
EYN/A
EPS(NY)-1.49
Fwd EYN/A
FCF(TTM)-0.7
FCFYN/A
OCF(TTM)-0.7
OCFYN/A
SpS0
BVpS4.51
TBVpS4.51
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -16.74%
ROE -17.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-17.72%
ROA(5y)-13.06%
ROE(3y)-18.43%
ROE(5y)-13.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 36.12%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 34.13
Quick Ratio 34.13
Altman-Z 81.88
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)27.81%
Cap/Depr(5y)144.68%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-35.29%
EPS Next Y-85.9%
EPS Next 2Y-52.17%
EPS Next 3Y-36.43%
EPS Next 5Y18.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-37.85%
EBIT Next 3Y-29.28%
EBIT Next 5Y16.72%
FCF growth 1Y-3.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3%
OCF growth 3YN/A
OCF growth 5YN/A

GH RESEARCH PLC / GHRS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GH RESEARCH PLC (GHRS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GHRS.


Can you provide the valuation status for GH RESEARCH PLC?

ChartMill assigns a valuation rating of 0 / 10 to GH RESEARCH PLC (GHRS). This can be considered as Overvalued.


What is the profitability of GHRS stock?

GH RESEARCH PLC (GHRS) has a profitability rating of 1 / 10.